Elizabeth Moyal-Jonathan

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Early metabolic reprogramming and carbonic anhydrase IX-mediated extracellular acidification drive radiotherapy-induced glioblastoma cell dedifferentiation.

Early metabolic reprogramming and carbonic anhydrase IX-mediated extracellular acidification drive radiotherapy-induced glioblastoma cell dedifferentiation.

Journal: Acta neuropathologica communications

Published: May 20, 2025

FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation.

FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation.

Journal: Cells

Published: May 12, 2025

RadioTransNet: Preclinical research network coordinated by the Société française de radiothérapie oncologique and Société française de physique médicale, 2025 update.

RadioTransNet: Preclinical research network coordinated by the Société française de radiothérapie oncologique and Société française de physique médicale, 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: May 07, 2025

PEA3 Transcription Factors, Role in Invasion, Proliferation and Radioresistance of Glioblastoma Stem Cells.

PEA3 Transcription Factors, Role in Invasion, Proliferation and Radioresistance of Glioblastoma Stem Cells.

Journal: Journal of cellular and molecular medicine

Published: November 21, 2024

Malignant Transformation in Pleomorphic Adenoma: The Impact of DNA Methylation Profiling and Pathogenic Mutations.

Malignant Transformation in Pleomorphic Adenoma: The Impact of DNA Methylation Profiling and Pathogenic Mutations.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: November 01, 2024

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 02, 2024

FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields.

FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields.

Journal: Cell death discovery

Published: June 03, 2024

Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a "molecular" glioblastoma.

Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a "molecular" glioblastoma.

Journal: The oncologist

Published: May 02, 2024

REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.

REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 02, 2024

The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.

The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.

Journal: Science advances

Published: November 03, 2023

Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance.

Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance.

Journal: Cancers

Published: September 26, 2023

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.

Journal: Frontiers in oncology

Published: July 29, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026